CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $50.5 million in its first quarter.The Cambridge, Massachusetts-based company said it had a loss of 74 cents per share.The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.The genome editing company posted revenue of $6.8 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $4.7 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT